EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry (Q35164306)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry |
scientific article |
Statements
1 reference
EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry (English)
1 reference
Pasi A Jänne
1 reference
Lynette M Sholl
1 reference
Yun Xiao
1 reference
Victoria Joshi
1 reference
Beow Y Yeap
1 reference
Leigh-Anne Cioffredi
1 reference
David M Jackman
1 reference
Charles Lee
1 reference
Neal I Lindeman
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference